Federal Intervention Results in Policy Shift at Major Hospital
Mount Sinai, one of the most prominent hospital networks in New York City, has agreed to halt all sex reassignment procedures for minors. This decision follows a federal investigation conducted by the Department of Justice under the current Trump administration. The hospital system provided services including hormonal therapy and various surgical interventions to thousands of patients. According to its 2025 annual report, the Institute for Advanced Medicine saw 4,931 transgender and gender-diverse patients, though specific data regarding the number of minors treated remains private.
Attorney General Todd Blanche stated that the federal government is prioritizing the accountability of medical providers that endanger children through these clinical practices. The formal agreement requires Mount Sinai to pay a financial penalty. Furthermore, the hospital will allocate $2 million toward free medical support for individuals who suffered negative outcomes from treatments they received as minors. This move signals a significant change in medical standards for large healthcare institutions.
Shifting Regulatory Standards and Government Oversight
President Trump issued an executive order shortly after taking office. Titled "Protecting Children from Chemical and Surgical Mutilation," the order directs federal agencies to stop funding gender reassignment procedures for youth. It also mandates that the Department of Justice enforce federal laws regarding genital mutilation and investigate potential violations of drug safety or medical billing standards. Authorities are looking into allegations of fraud, specifically the use of incorrect diagnostic codes to secure payments from federal health insurance programs.
Recent regulatory actions have aimed to move away from guidance provided by the World Professional Association for Transgender Health (WPATH). The Federal Trade Commission and several state attorneys general are currently suing WPATH. These lawsuits claim that the association made false assertions about the medical necessity and safety of pediatric transition services. Mount Sinai previously based its clinical protocols on WPATH guidelines, with several high-level staff members having co-authored them.
Broader Industry Impacts and What Lies Ahead
Mount Sinai is not the first institution to change its policies in the face of these investigations. Other organizations, including Texas Children’s Hospital, the Cleveland Clinic Foundation, and Connecticut Children’s Hospital, have already ended similar programs for minors. This trend suggests a widespread move by major medical providers to preempt further federal litigation and adjust to the administration's stance on pediatric care.
Assistant Attorney General Brett Shumate noted that the government expects more hospitals to review their practices in light of growing evidence. The Department of Justice characterized Mount Sinai as solution-driven throughout the investigative process. The hospital's leadership has stated that the settlement serves to protect both patient confidentiality and the institution's clinicians. The full impact of this shift on pediatric healthcare in the United States remains a developing story. Observers should monitor whether other state-level courts or medical boards follow suit in challenging these clinical standards.